Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Medtronic heart valve receives panel approval

Medtronic heart valve receives panel approval

24th July 2009

Medtronic has announced that a new device designed to help in the treatment of adults and children with congenital heart disease has received approval by an influential panel.

The company claims that its Melody Transcatheter Pulmonary Valve was given unanimous backing by the Circulatory System Devices Panel, a group which informs the Food and Drug Administration (FDA).

If given the official green light, the device will allow dysfunctional pulmonary valves to be treated without the need to open the chest in surgery.

Dr John Liddicoat, vice-president and general manager of the structural heart division, part of the cardiovascular business at Medtronic, said the company is “very pleased” by the development.

“By providing a less invasive option and therefore delaying even one open-heart surgery, we can improve the lives of thousands of congenital heart disease patients,” he explained.

In other Medtronic news, the company announced this week that its voluntary recall of its Intrepid Intervertebral Body Fusion Device earlier this year has been classified as a Class II recall by the FDA.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.